EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevention of axonal loss after immediate dosage titration of immunoglobulin in multifocal motor neuropathy

Ali Al-Zuhairy iD, Johannes Jakobsen, Christian Krarup

European Journal of Neurology · 2024

DOI: 10.1111/ene.16305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Ali Al-Zuhairy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark. Hauptthemen laut MEDLINE: Axons, Polyneuropathies. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Takeda Pharmaceutical Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To evaluate whether ongoing axonal loss can be prevented in multifocal motor neuropathy (MMN) treated with immunoglobulin G (IgG), a group of patients with a median disease duration of 15.7 years (range: 8.3–37.8), treated with titrated dosages of immunoglobulins, was studied electrophysiologically at time of diagnosis and at follow‐up.

Results

At follow‐up, the Z‐score of the compound motor action potential amplitude of the median, fibular, and tibial nerves and the neurological performances were determined. In seven patients with a treatment‐free period of 0.3 years (0.2–0.4), there was no progression of axonal loss ( p = 0.2), whereas a trend toward further axonal loss by 1.3 Z‐scores (0.9–17.0, p = 0.06) was observed in five patients with a treatment‐free period of 4.0 years (0.9–9.0). The axonal loss in the group with a short treatment delay was significantly smaller than in the group with a longer treatment delay ( p = 0.02). Also, there was an association between treatment delay and ongoing axonal loss ( p = 0.004). The electrophysiological findings at follow‐up were associated with the isokinetic strength performance, the neurological impairment score, and the disability, supporting the clinical relevance of the electrophysiological estimate of axonal loss.

Conclusion

Swift initiation of an immediately titrated IgG dosage can prevent further axonal loss and disability in continuously treated MMN patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AxonsPolyneuropathiesHumansMaleFemaleMiddle AgedAdultAgedNeural ConductionAction PotentialsImmunoglobulin GMotor Neuron DiseaseFollow-Up StudiesImmunoglobulins, Intravenous

Stichwörter der Autor:innen

inflammatory neuropathymultifocal motor neuropathyneurological disordersneuromuscular diseases

Substanzen

Immunoglobulin GImmunoglobulins, Intravenous

Autor:innen und Institutionen

  • Department of Neurology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
  • Department of Clinical Neurophysiology, Rigshospitalet, Copenhagen, Denmark.
  • Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Ali Al-Zuhairy

Förderung

  • Takeda Pharmaceutical Company

Zitieren

APA

Al-Zuhairy, A., Jakobsen, J., & Krarup, C. (2024). Prevention of axonal loss after immediate dosage titration of immunoglobulin in multifocal motor neuropathy. European Journal of Neurology. https://doi.org/10.1111/ene.16305

Vancouver

Al-Zuhairy A, Jakobsen J, Krarup C. Prevention of axonal loss after immediate dosage titration of immunoglobulin in multifocal motor neuropathy. European Journal of Neurology. 2024. doi:10.1111/ene.16305

BibTeX
@article{AlZuhairy2024,
  author = {Al-Zuhairy, Ali and Jakobsen, Johannes and Krarup, Christian},
  title = {Prevention of axonal loss after immediate dosage titration of immunoglobulin in multifocal motor neuropathy},
  journal = {European Journal of Neurology},
  year = {2024},
  doi = {10.1111/ene.16305}
}
Kostenlos starten →